Meanwhile, concomitant overexpression of MDM2 and OV6 predicted rapid tumor relapse and a poor prognosis for HBV-related HCC patients (Figure 3h and Supplementary Table S2). Here, MDM2 is linked to hepatocellular carcinoma.